Keating Investment Counselors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$616K Sell
2,424
-475
-16% -$111K 0.17% 39
2026
Q1
$709K Sell
2,899
-7,338
-72% -$1.71M 0.18% 37
2025
Q4
$2.12M Sell
10,237
-393
-4% -$77.7K 0.59% 29
2025
Q3
$1.97M Sell
10,630
-615
-5% -$105K 0.56% 30
2025
Q2
$1.72M Sell
11,245
-1,290
-10% -$198K 0.52% 29
2025
Q1
$2.08M Sell
12,535
-2,509
-17% -$393K 0.63% 30
2024
Q4
$2.18M Sell
15,044
-150
-1% -$23.2K 0.68% 29
2024
Q3
$2.46M Sell
15,194
-905
-6% -$144K 0.74% 27
2024
Q2
$2.35M Sell
16,099
-392
-2% -$58.3K 0.76% 25
2024
Q1
$2.61M Sell
16,491
-6,934
-30% -$1.1M 0.84% 28
2023
Q4
$3.67M Sell
23,425
-539
-2% -$82.6K 1.31% 25
2023
Q3
$3.73M Sell
23,964
-905
-4% -$149K 1.27% 24
2023
Q2
$4.12M Sell
24,869
-1,730
-7% -$279K 1.49% 22
2023
Q1
$4.12M Sell
26,599
-1,735
-6% -$280K 1.56% 23
2022
Q4
$5.01M Buy
28,334
+5,886
+26% +$1.02M 1.96% 20
2022
Q3
$3.67M Sell
22,448
-5,435
-19% -$920K 1.64% 23
2022
Q2
$4.95M Sell
27,883
-3,020
-10% -$538K 2.09% 18
2022
Q1
$5.48M Sell
30,903
-811
-3% -$138K 2.35% 18
2021
Q4
$5.42M Sell
31,714
-507
-2% -$83K 2.4% 17
2021
Q3
$5.2M Sell
32,221
-360
-1% -$61.4K 2.44% 18
2021
Q2
$5.37M Sell
32,581
-2,040
-6% -$338K 2.46% 17
2021
Q1
$5.69M Sell
34,621
-1,730
-5% -$280K 2.73% 14
2020
Q4
$5.72M Sell
36,351
-200
-0.5% -$29.5K 2.86% 13
2020
Q3
$5.44M Sell
36,551
-900
-2% -$133K 2.85% 14
2020
Q2
$5.27M Sell
37,451
-1,705
-4% -$248K 2.9% 13
2020
Q1
$5.13M Sell
39,156
-2,718
-6% -$386K 3.14% 11
2019
Q4
$6.11M Sell
41,874
-925
-2% -$125K 2.67% 12
2019
Q3
$5.54M Sell
42,799
-2,695
-6% -$355K 2.49% 15
2019
Q2
$6.34M Sell
45,494
-12,568
-22% -$1.74M 2.83% 13
2019
Q1
$8.12M Sell
58,062
-1,470
-2% -$197K 3.67% 6
2018
Q4
$7.68M Sell
59,532
-1,397
-2% -$195K 3.89% 5
2018
Q3
$8.42M Sell
60,929
-6,796
-10% -$903K 3.62% 6
2018
Q2
$8.22M Sell
67,725
-860
-1% -$107K 3.9% 5
2018
Q1
$8.79M Sell
68,585
-3,311
-5% -$448K 4.05% 5
2017
Q4
$10M Sell
71,896
-805
-1% -$112K 4.27% 4
2017
Q3
$9.45M Sell
72,701
-650
-0.9% -$86.2K 4.11% 4
2017
Q2
$9.7M Sell
73,351
-1,690
-2% -$216K 4.25% 4
2017
Q1
$9.35M Sell
75,041
-1,895
-2% -$226K 4.16% 3
2016
Q4
$8.86M Sell
76,936
-4,420
-5% -$511K 4.18% 3
2016
Q3
$9.61M Sell
81,356
-205
-0.3% -$24.9K 4.68% 2
2016
Q2
$9.89M Buy
81,561
+425
+0.5% +$48.3K 4.85% 2
2016
Q1
$8.78M Buy
81,136
+1,900
+2% +$197K 4.29% 4
2015
Q4
$8.14M Sell
79,236
-10
-0% -$1.01K 4.08% 4
2015
Q3
$7.4M Buy
79,246
+325
+0.4% +$31.4K 3.98% 3
2015
Q2
$7.69M Sell
78,921
-575
-0.7% -$57.6K 3.92% 3
2015
Q1
$8M Buy
79,496
+380
+0.5% +$38.6K 4% 3
2014
Q4
$8.27M Sell
79,116
-110
-0.1% -$11.6K 4.13% 4
2014
Q3
$8.45M Sell
79,226
-4,335
-5% -$450K 4.37% 2
2014
Q2
$8.74M Sell
83,561
-1,203
-1% -$122K 4.21% 1
2014
Q1
$8.33M Buy
84,764
+231
+0.3% +$21.4K 4.15% 2
2013
Q4
$7.74M Sell
84,533
-549
-0.6% -$50.6K 3.95% 3
2013
Q3
$7.38M Sell
85,082
-1,739
-2% -$156K 4.11% 1
2013
Q2
$7.45M Buy
+86,821
New +$7.37M 4.2% 2

Other funds holding JNJ

Keating Investment Counselors's JNJ Position: Q2 2026 in Review

Keating Investment Counselors reduced its Johnson & Johnson (JNJ) stake by 16% in Q2 2026, selling an estimated $111K and leaving 2,424 shares worth $616K. The position accounts for 0.17% of the portfolio, ranked #39.

Keating Investment Counselors first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. The position peaked at $10M in Q4 2017. 1,657 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Keating Investment Counselors held 2,424 shares of Johnson & Johnson worth $616K as of Q2 2026.
  • Keating Investment Counselors sold 475 Johnson & Johnson shares in Q2 2026, an estimated $111K.
  • Johnson & Johnson made up 0.17% of Keating Investment Counselors's portfolio in Q2 2026, its #39 holding.
  • Keating Investment Counselors first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • Keating Investment Counselors's Johnson & Johnson position peaked at $10M in Q4 2017.
  • 1,657 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Keating Investment Counselors's 13F filing for Q2 2026, filed 16 Jul 2026.